Cytokinetics (CYTK) had its price target raised by Leerink Partners from $83.00 to $84.00. They now have an "outperform" rating on the stock.
Cytokinetics (CYTK) had its "neutral" rating reaffirmed by Bank of America Corporation.
Cytokinetics (CYTK) had its price target raised by Needham & Company LLC from $84.00 to $85.00. They now have a "buy" rating on the stock.
Cytokinetics (CYTK) had its price target raised by Citizens Jmp from $88.00 to $96.00. They now have a "market outperform" rating on the stock.
Cytokinetics Q4 Earnings Call Highlights [Yahoo! Finance]